Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
| Autor: | C. Laouani, Monia Karmeni, Imen Ben Hassine, A. Rezgui, Fatma Ben Fredj, J. Anoun, A. Mzabi, M. Thabet, Sahar Makki |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Ankylosing spondylitis takayasu’s arteritis business.industry tumor necrosis factor Immunology Takayasu's arteritis Inflammation Context (language use) medicine.disease Dermatology Rheumatology Concomitant Large vessel vasculitis ankylosing spondylitis medicine Immunology and Allergy Medicine Arteritis medicine.symptom Vasculitis business Case-Based Review |
| Zdroj: | Rheumatology, Vol 59, Iss 2, Pp 111-114 (2021) Reumatologia |
| ISSN: | 2084-9834 0034-6233 |
| Popis: | Coexistence of spondyloarthritis (SpA) and Takayasu’s arteritis is not a common finding, but such cases have been discussed, particularly in the context of choice of therapy. Inhibition of inflammation by tumor necrosis factor inhibitors (TNFi) is a key aspect of the treatment of SpA and also positive effects of such treatment in concomitant large vessel vasculitis have been reported. However, TNFi is also associated with the possibility of initiating vasculitis. The present article based on a case study and the available literature is an attempt to discuss coexistence of these two diseases and the impact of treatment with biological drugs from the anti-TNF group in the course of SpA with Takayasu’s arteritis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|